Mitobronitol

Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent.

Also Known As:

Myelobromol; NSC-94,100; NSC-94100; NSC 94,100; NSC 94100; NSC94,100; NSC94100; Dibromomannitol; D-Mannitol, 1,6-dibromo-1,6-dideoxy-

Networked: 39 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Alcohols: 595
  - Sugar Alcohols: 143
    - Mannitol: 3222
      - Mitobronitol: 39
        1,2-anhydro-6-bromomannitol
Carbohydrates: 22023
- Sugar Alcohols: 143
  - Mannitol: 3222
    - Mitobronitol: 39
      - 1,2-anhydro-6-bromomannitol

Experts

1.	Jeney, András: 1 article (12/2017)
2.	Kralovánszky, Judit: 1 article (12/2017)
3.	Lapis, Károly: 1 article (12/2017)
4.	Fujita, Haruyuki: 1 article (12/2006)
5.	Kurata, Masayuki: 1 article (12/2006)
6.	Maeda, Akinori: 1 article (12/2006)
7.	Matsushita, Akiko: 1 article (12/2006)
8.	Mori, Minako: 1 article (12/2006)
9.	Nagai, Kenichi: 1 article (12/2006)
10.	Nagai, Yuya: 1 article (12/2006)

Related Diseases

1.	Mucositis 04/01/1998 - "A radiation-free, non-myeloablative, myelosuppressive protocol, containing dibromomannitol and cytosine arabinoside, that remarkably reduced the frequency of transplant-related complications, such as veno-occlusive liver disease (VOLD), severe mucositis, bacterial sepsis, hemorrhagic cystitis, interstitial pneumonitis, has been applied in 19 CML patients, allotransplanted from identical siblings. "
2.	Sepsis (Septicemia) 04/01/1998 - "A radiation-free, non-myeloablative, myelosuppressive protocol, containing dibromomannitol and cytosine arabinoside, that remarkably reduced the frequency of transplant-related complications, such as veno-occlusive liver disease (VOLD), severe mucositis, bacterial sepsis, hemorrhagic cystitis, interstitial pneumonitis, has been applied in 19 CML patients, allotransplanted from identical siblings. "
3.	Interstitial Lung Diseases (Interstitial Lung Disease) 04/01/1998 - "A radiation-free, non-myeloablative, myelosuppressive protocol, containing dibromomannitol and cytosine arabinoside, that remarkably reduced the frequency of transplant-related complications, such as veno-occlusive liver disease (VOLD), severe mucositis, bacterial sepsis, hemorrhagic cystitis, interstitial pneumonitis, has been applied in 19 CML patients, allotransplanted from identical siblings. "
4.	Liver Diseases (Liver Disease) 04/01/1998 - "A radiation-free, non-myeloablative, myelosuppressive protocol, containing dibromomannitol and cytosine arabinoside, that remarkably reduced the frequency of transplant-related complications, such as veno-occlusive liver disease (VOLD), severe mucositis, bacterial sepsis, hemorrhagic cystitis, interstitial pneumonitis, has been applied in 19 CML patients, allotransplanted from identical siblings. "
5.	Hemorrhagic Cystitis 04/01/1998 - "A radiation-free, non-myeloablative, myelosuppressive protocol, containing dibromomannitol and cytosine arabinoside, that remarkably reduced the frequency of transplant-related complications, such as veno-occlusive liver disease (VOLD), severe mucositis, bacterial sepsis, hemorrhagic cystitis, interstitial pneumonitis, has been applied in 19 CML patients, allotransplanted from identical siblings. "

Related Drugs and Biologics

1.	Cytarabine (Cytosar-U)
2.	Busulfan (Busulfex)
3.	Hydroxyurea (Hydrea)
4.	desacetamidocolchicine
5.	Mitobronitol
6.	Cytostatic Agents
7.	Cyclophosphamide (Cytoxan)
8.	Nimustine
9.	Dianhydrogalactitol
10.	Dextrans (Dextran)

Related Therapies and Procedures

1.	Therapeutics
2.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
3.	Maintenance Chemotherapy
4.	Transplantation
5.	Drug Therapy (Chemotherapy)